Pembrolizumab Plus Docetaxel Versus Docetaxel for Previously Treated Metastatic Castration-Resistant Prostate Cancer: The Randomized, Double-Blind, Phase III KEYNOTE-921 Trial
The addition of pembrolizumab to docetaxel did not significantly improve efficacy outcomes for participants with previously treated mCRPC. The current standard of care remains unchanged.
Authors
- Margitta Retz
- Ray McDermott (ORCID: https://orcid.org/0000-0002-8952-4315)
- Karim Fizazi (ORCID: https://orcid.org/0000-0002-6068-9474)
- Éric Lévesque (ORCID: https://orcid.org/0000-0001-5986-3458)
- Loı̈c Mourey (ORCID: https://orcid.org/0000-0001-5583-8036)
- Nobuaki Matsubara (ORCID: https://orcid.org/0000-0002-9203-4245)
- Christian Poehlein (ORCID: https://orcid.org/0000-0002-3348-3059)
- Seok‐Soo Byun (ORCID: https://orcid.org/0000-0001-9356-9500)
- Andries M. Bergman (ORCID: https://orcid.org/0000-0001-5223-2549)
- Rustem Gafanov (ORCID: https://orcid.org/0000-0002-7592-0392)
- Andrew J. Armstrong (ORCID: https://orcid.org/0000-0001-7012-1754)
- Howard Gurney (ORCID: https://orcid.org/0000-0003-0217-5261)
- Meital Levartovsky
- Daniel Peter Petrylak (ORCID: https://orcid.org/0000-0001-6165-5797)
- Gero Kramer
- Ray Manneh Kopp (ORCID: https://orcid.org/0000-0002-8106-9741)
- Charles Schloss (ORCID: https://orcid.org/0000-0002-5106-3082)
- Sergio Bracarda (ORCID: https://orcid.org/0000-0002-0703-2959)
- Paweł Zalewski (ORCID: https://orcid.org/0000-0001-8453-7785)
- Tilman Todenhöfer (ORCID: https://orcid.org/0000-0003-4432-2741)
- Maria De Santis (ORCID: https://orcid.org/0000-0002-3196-1336)
- Russell K. Pachynski (ORCID: https://orcid.org/0000-0002-8966-7631)
- Raffaele Ratta (ORCID: https://orcid.org/0000-0002-2445-415X)
- Xin Tong Li
- Ernesto Korbenfeld (ORCID: https://orcid.org/0000-0001-6343-9991)
- Winald R. Gerritsen
Institutions
- Merck & Co., Inc., Rahway, NJ, USA (United States) (US)
- Radboud University Nijmegen (NL)
- Duke University (US)
- Washington University in St. Louis (US)
- Université Paris-Saclay (FR)
- Lakeridge Health (CA)
- Sheba Medical Center (IL)
- Institut Gustave Roussy (FR)
- TUM Klinikum (DE)
- Yale Cancer Center (US)
- Radboud University Medical Center (NL)
- Seoul National University Bundang Hospital (KR)
- The Netherlands Cancer Institute (NL)
- Popular University of Cesar (CO)
- Cancer Trials Ireland (IE)
- Federal State Budgetary Institution Russian Scientific Center of Roentgenoradiology (RU)
- Oncode Institute (NL)
- St. Vincent's University Hospital (IE)
- Hôtel-Dieu de Québec (CA)
- Azienda Ospedaliera S.Maria (IT)
- Institut Claudius Regaud (FR)
- National Cancer Center Hospital East (JP)
- Hospital Británico de Buenos Aires (AR)
- Hôpital Foch (FR)
- Université Laval (CA)
- Medical University of Vienna (AT)
- Charité - Universitätsmedizin Berlin (DE)
- Macquarie University (AU)
Publication Details
- Journal
- Journal of Clinical Oncology
- Published
- 2025-03-05
- DOI
- https://doi.org/10.1200/jco-24-01283
- Citations
- 34
- Primary Topic
- Prostate Cancer Treatment and Research
- Type
- article
- Field-Weighted Citation Impact
- 51.62